Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela B Allen

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Expert Opinion on Investigational Drugs|December 13, 2017
Investigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcomeAndres Chang, Danielle Schlafer, Christopher R Flowers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2013
Scedosporium apiospermum soft tissue infection as the initial presentation of acute myeloid leukemia: a case reportPamela B Allen, Rima Koka, Michael E Kleinberg, et al.
Leukemia & Lymphoma|February 28, 2020
A systematic review of therapeutic regimens for older patients with newly diagnosed Hodgkin lymphomaPamela B Allen, Amy Ayers, Madhusmita Behera, et al.
Leukemia & Lymphoma|June 20, 2020
Risk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL)Pamela B Allen, Jeffrey Switchenko, Amy Ayers, et al.
Leukemia & Lymphoma|April 28, 2022
African American and Caucasian patients with Sézary syndrome have no differences in outcomes at an ethnically diverse urban medical centerDylan J Martini, Subir Goyal, Jeffrey M Switchenko, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 29, 2019
Influenza Vaccination Documentation Rates During the First Year After Diagnosis of Diffuse Large B Cell LymphomaAndres Chang, Jackelyn B Payne, Pamela B Allen, et al.
JAMA Dermatology|September 7, 2022
Clinical Presentation and Outcome Differences Between Black Patients and Patients of Other Races and Ethnicities With Mycosis Fungoides and Sézary SyndromePamela B Allen, Subir Goyal, Tim Niyogusaba, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 25, 2020
Maintenance Therapy for Cutaneous T-cell Lymphoma After Total Skin Electron Irradiation: Evidence for Improved Overall Survival With Ultraviolet TherapyMatthew R Kudelka, Jeffrey M Switchenko, Mary Jo Lechowicz, et al.
JAMA Dermatology|June 30, 2021
T-Cell Receptor Gene Rearrangement Clonality, Flow Cytometry Status, and Associated Outcomes in Early-Stage Cutaneous T-Cell LymphomaJennifer A Marks, Jeffrey M Switchenko, Dylan J Martini, et al.
Leukemia & Lymphoma|June 8, 2022
Mitigation strategies among cutaneous T-cell lymphoma patients with positive <i>Staphylococcus aureus</i> skin and soft tissue cultures have unclear impacts on the risk of subsequent bacteremiaPamela B Allen, Subir Goyal, Jeffrey Switchenko, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Expert Opinion on Investigational Drugs|December 13, 2017
Investigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcomeAndres Chang, Danielle Schlafer, Christopher R Flowers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2013
Scedosporium apiospermum soft tissue infection as the initial presentation of acute myeloid leukemia: a case reportPamela B Allen, Rima Koka, Michael E Kleinberg, et al.
Leukemia & Lymphoma|February 28, 2020
A systematic review of therapeutic regimens for older patients with newly diagnosed Hodgkin lymphomaPamela B Allen, Amy Ayers, Madhusmita Behera, et al.
Leukemia & Lymphoma|June 20, 2020
Risk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL)Pamela B Allen, Jeffrey Switchenko, Amy Ayers, et al.
Leukemia & Lymphoma|April 28, 2022
African American and Caucasian patients with Sézary syndrome have no differences in outcomes at an ethnically diverse urban medical centerDylan J Martini, Subir Goyal, Jeffrey M Switchenko, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 29, 2019
Influenza Vaccination Documentation Rates During the First Year After Diagnosis of Diffuse Large B Cell LymphomaAndres Chang, Jackelyn B Payne, Pamela B Allen, et al.
JAMA Dermatology|September 7, 2022
Clinical Presentation and Outcome Differences Between Black Patients and Patients of Other Races and Ethnicities With Mycosis Fungoides and Sézary SyndromePamela B Allen, Subir Goyal, Tim Niyogusaba, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 25, 2020
Maintenance Therapy for Cutaneous T-cell Lymphoma After Total Skin Electron Irradiation: Evidence for Improved Overall Survival With Ultraviolet TherapyMatthew R Kudelka, Jeffrey M Switchenko, Mary Jo Lechowicz, et al.
JAMA Dermatology|June 30, 2021
T-Cell Receptor Gene Rearrangement Clonality, Flow Cytometry Status, and Associated Outcomes in Early-Stage Cutaneous T-Cell LymphomaJennifer A Marks, Jeffrey M Switchenko, Dylan J Martini, et al.
Leukemia & Lymphoma|June 8, 2022
Mitigation strategies among cutaneous T-cell lymphoma patients with positive <i>Staphylococcus aureus</i> skin and soft tissue cultures have unclear impacts on the risk of subsequent bacteremiaPamela B Allen, Subir Goyal, Jeffrey Switchenko, et al.
Pageof 4